Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.

Clinical transplantation - 1 Dec 2015

Nelson Laerke M, Penninga Luit, Villadsen Gerda E, Mølgaard Henning, Eiskjaer Hans, Hillingsø Jens G, Rasmussen Allan

Abstract excerpt

BACKGROUND: Familial transthyretin (TTR) amyloidosis is caused by different TTR mutations resulting in different clinical phenotypes of the disease. The Leu111Met mutation causes severe restrictive cardiomyopathy. Liver transplantation (LTx) is an established treatment option for patients with TTR amyloidosis; however, information on outcome after isolated LTx in patients with Leu111Met mutation amyloidosis is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial
Share to Cardiomyopathies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Echocardiography

Share to Follow-Up Studies

Share to Graft Survival

Share to Liver Transplantation

Share to Prognosis

Share to Risk Factors

Source

Identifiers

PMID: 26361241
DOI: 10.1111/ctr.12633

Genes

TTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.PMID 26361241Read ↗

Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.Semantic proximity Read ↗

Liver transplantation in transthyretin amyloidosis: issues and challenges.Semantic proximity Read ↗

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?Semantic proximity Read ↗

Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.Semantic proximity Read ↗

Liver transplantation for hereditary transthyretin amyloidosis.Semantic proximity Read ↗

Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation.Semantic proximity Read ↗

Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience.Semantic proximity Read ↗

Outcome of liver transplantation for familial amyloidotic polyneuropathy.Semantic proximity Read ↗

Successful heart and liver transplantation in a Swiss patient with Glu89Lys transthyretin amyloidosis.Semantic proximity Read ↗

Prediction of Long-Term Survival After Liver Transplantation for Familial Transthyretin AmyloidosisSemantic proximity Read ↗

Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.Semantic proximity Read ↗

Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.